Microbix Biosystems Inc. (MBX.TO)
| Previous Close | 0.2850 |
| Open | 0.2850 |
| Bid | 0.2850 x 0 |
| Ask | 0.2900 x 0 |
| Day's Range | 0.2850 - 0.2850 |
| 52 Week Range | 0.2300 - 0.4700 |
| Volume | |
| Avg. Volume | 77,342 |
| Market Cap | 39.132M |
| Beta (5Y Monthly) | 0.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 02, 1999 |
| 1y Target Est | N/A |
- GlobeNewswire
Microbix Presenting at Florida Capital Event Conference
Meetings with Growth-Oriented Investors, November 17 to 19, 2023MISSISSAUGA, Ontario, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Florida Capital Event Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Turnberry, in Aventura, Florida, November 17 to 19, 2023. Microbix’s CEO & President, Cameron
- GlobeNewswire
Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market
Sequel Pharma Reconfirms Kinlytic® urokinase Support for Catheter Clearance IndicationMISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the reconfirmation of its agreement (“Agreement”) with Sequel Pharma, LLC (“Sequel”) to return Kinlytic® urokinase (“Kinlytic”) to market, initially for dissolving blood clots that block venous catheters (“Catheter Clearance”) in t
- GlobeNewswire
Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays
Onboarding Tools and Quality Controls for Extended Genotype HPV AssaysMISSISSAUGA, Ontario and TRIESTE, Italy, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Ulisse Biomed S.p.A. (BIT: UBM, Ulisse), a company developing innovative diagnostics, theranostics, and therapeutics. The companies are collaborating to make Microbix’s Quality Assessment Products (“QAPs™”)
